Health product recall

Sodium Acetate Injection, USP: Particulate matter

Last updated

Summary

Product
Sodium Acetate Injection, USP
Issue
Health products - Product quality
What to do

See instructions below. 

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP

DIN 02139529

Solution

Sodium Acetate 328 MG/ML

6125334, 6125335

Issue

Presence of particulate matter in affected lots.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers, Healthcare Establishments

Details
Original published date: 2022-03-07
Alert / recall type
Health product recall
Category
Health product - Drugs
Companies

Fresenius Kabi Canada Ltd.

165 Galaxy Boulevard Suite 100,

Toronto, Ontario,

M9W 0C8

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-63965